Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells
CDC · CDC OFFICE OF ACQUISITION SERVICES
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75D301-26-R-73503 in this department, oldest first.
- Jul 28, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
Who won similar work
12 award notices on SAM.gov in the last 24 months. Matched by: Same office (CDC OFFICE OF ACQUISITION SERVICES), same product/service code (PSC) 6505.
Single-winner award sizes (12): middle half $65.6M to $1.6B, median $218.0M; range $9.1M to $4.5B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GLAXOSMITHKLINE, LLC | 3 | $1.7B | Mar 27, 2026 |
| SEQIRUS USA INC | 2 | $663.9M | Dec 31, 2024 |
| SANOFI PASTEUR INC. | 2 | $233.3M | Dec 31, 2024 |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $61.0M | Dec 31, 2024 |
| MERCK SHARP & DOHME LLC · $MRK · $60.1B | 1 | $4.5B | Mar 27, 2026 |
| PFIZER INC · $PFE · $59.6B | 1 | $2.1B | Mar 27, 2026 |
| SANOFI VACCINES US INC. | 1 | $1.9B | Mar 27, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $MRK reported $60.1B revenue in FY2025. The median single-winner award in these 12 past awards, $218.0M, is 0.4% of that. 10-K
- $PFE reported $59.6B revenue in FY2025. The median single-winner award in these 12 past awards, $218.0M, is 0.4% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Mar 27, 2026GLAXOSMITHKLINE, LLC$1.5BVaccines for Children (VFC) FY26
- Mar 27, 2026SANOFI VACCINES US INC.$1.9BVaccines for Children (VFC) FY26
- Mar 27, 2026PFIZER INC$2.1BVaccines for Children (VFC) FY26
- Mar 27, 2026MERCK SHARP & DOHME LLC$4.5BVaccines for Children (VFC) FY26
- Dec 31, 2024GLAXOSMITHKLINE, LLC$182.6MPediatric Flu Vaccine � 2025-2026
- Dec 31, 2024SANOFI PASTEUR INC.$70.2MAdult Flu Vaccines 2025-2026
- Dec 31, 2024SEQIRUS USA INC$253.3MAdult Flu Vaccines 2025-2026
- Dec 31, 2024SEQIRUS USA INC$410.6MPediatric Flu Vaccine � 2025-2026
- Dec 31, 2024SANOFI PASTEUR INC.$163.1MPediatric Flu Vaccine � 2025-2026
- Dec 31, 2024ASTRAZENECA PHARMACEUTICALS LP$9.1MAdult Flu Vaccines 2025-2026
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (9 filings)
- 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
- $243K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 6 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 3 insider buys and 8 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.